Valuation: EMV Capital plc

Market Cap 14.96M 20.2M 17.51M 16.41M 28.15M 1.93B 28.6M 193M 75.43M 965M 75.82M 74.18M 3.22B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 13.93M 18.81M 16.3M 15.28M 26.22M 1.79B 26.64M 180M 70.25M 898M 70.61M 69.08M 3B EV / Sales 2026 *
4.06x
EV / Sales 2027 * 4.05x
Free-Float
52.46%
Yield 2026 *
-
Yield 2027 * -
1 day-1.35%
1 week-1.35%
Current month-1.35%
1 month+0.53%
3 months+17.28%
6 months-1.35%
Current year-7.41%
1 week 52
Extreme 52
55
1 month 51.66
Extreme 51.66
55
Current year 44
Extreme 44
62
1 year 40
Extreme 40
62
3 years 34
Extreme 34
80.5
5 years 34
Extreme 34
137
10 years 9.75
Extreme 9.75
846
Manager TitleAgeSince
Chief Executive Officer 50 2020-04-30
Director of Finance/CFO 45 2025-11-30
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 50 2019-10-13
Director/Board Member 47 2022-12-08
Chairman 61 2023-01-31
Date Insider Type Main position Quantity % Market Cap.
1/8/26 Buy 7,000 0.0250%
1/8/26 Sell 7,000 0.0250%
12/19/25 Buy

Director

34,484 0.1242%
Change 5-day change 1-year change 3-year change Capi.($)
-1.35%-1.35%+4.51%-16.23% 20.2M
-0.65%+2.30%+68.40%+27.21% 3.64B
+1.99%-0.70%-12.91%-1.28% 3.13B
+0.81%+0.40%+44.01%+26.52% 2.02B
+0.62%+6.42%+85.51%+169.19% 1.46B
0.00%0.00%-1.72%-7.02% 727M
+8.39%+24.35%+178.89%+241.17% 658M
+2.07%+2.07%+0.68%-5.13% 408M
0.00%0.00%-40.68%-75.18% 389M
0.00%+1.63%+0.54%-13.02% 369M
Average +0.94%+3.31%+32.72%+34.62% 1.28B
Weighted average by Cap. +0.42%+2.91%+40.86%+39.99%

Financials

2026 *2027 *
Net sales 3.43M 4.63M 4.01M 3.76M 6.45M 442M 6.56M 44.29M 17.29M 221M 17.38M 17M 738M 3.75M 5.06M 4.39M 4.12M 7.06M 483M 7.17M 48.46M 18.92M 242M 19.01M 18.6M 807M
Net income - -
Net Debt -1.03M -1.39M -1.2M -1.13M -1.94M -133M -1.97M -13.29M -5.19M -66.34M -5.21M -5.1M -221M 233K 314K 272K 255K 438K 29.99M 445K 3.01M 1.17M 15.01M 1.18M 1.15M 50.07M
Logo EMV Capital plc
EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It focuses on generating returns for investors from the sectors and technologies. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its portfolio includes AMR Bio, Wanda Health, Deeptech Recycling Technologies, EpiBone, Sofant Technologies, Q-Bot, and others. Its portfolio, Glycotest, is a liver disease diagnostics company commercializing novel and unique blood tests for life-threatening liver cancers and fibrosis-cirrhosis. ProAxsis Limited is a commercial biomarker-led research company supporting drug development and clinical research through specialist biomarker insights.
Employees
21
Date Price Change Volume
26-08-14 GBX 52.78 -1.35% 22,987
26-08-13 GBX 53.50 0.00% 3,855
26-08-12 GBX 53.50 0.00% 16,018
26-08-11 GBX 53.50 0.00% 77
26-08-10 GBX 53.50 0.00% 5,451
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5350GBP
Average target price
1.320GBP
Spread / Average Target
+146.73%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMVC Stock